Company
VYNE Therapeutics Inc. (VYNE)
Standardized SEC financial data for VYNE Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001566044 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
13.8%
Return on equity
-95.4%
ROIC
-628.7%
Free cash flow
-$33.1M
Debt / equity
0.00×
Current ratio
12.53×
EPS (diluted)
$-0.62
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $21.0M | $931K | $477K | $424K | $501K | $570K |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $59.4M | $42.9M | $31.0M | $30.7M | $19.9M | $24.0M |
| Inventory |
Cash flow
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | -$56.4M | -$29.2M | -$25.3M | -$34.0M | -$33.1M |
| Capital expenditures |
Get VYNE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VYNE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VYNE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"